# Brimonidine

## Mirvaso 3mg/gm gel 30gm

| 藥物代碼           | EMIR3                                                                                                                                                                                                                                           |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Symptomatic treatment of facial erythema of rosacea in adult patients.                                                                                                                                                                          |
| 副作用             | Flushing, erythema, pruritus, skin burning sensation.                                                                                                                                                                                           |
| 禁忌               | Hypersensitivity. Patients receiving MAOIs (eg, selegeline or moclobemide) & tricyclic (eg, imipramine) or tetracyclic (eg, maprotiline, mianserin or mirtazapin) antidepressants. Do not use in childn or adolescents 2-18 yr or childn <2 yr. |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                            |
| 用法用量           | 1 application/24 hr at any time as long as facial erythema is present. Max daily recommended dose: 1 g in total wt divided into 5 pea size amounts on forehead, cheeks, nose & chin.                                                            |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                    |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                    |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                        |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                             |
| 附帶說明           | N/A                                                                                                                                                                                                                                             |
| 哺乳期用藥建議     | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                  |
| 附帶說明           | 藥品仿單:懷孕建議: 因資料有限，最好不要在懷孕期間使用Mirvaso。  哺乳建議:不應於哺乳期間使用。                                                                                                                                                   |
| 注射劑給藥建議途徑 | EXT                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                             |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                             |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                             |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                             |
| 注意事項           | N/A                                                                                                                                                                                                                                             |

